Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety of Tirofiban in Acute Ischemic Stroke

Trial Profile

Safety of Tirofiban in Acute Ischemic Stroke

Phase of Trial: Phase II

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Acronyms SaTIS
  • Most Recent Events

    • 18 Aug 2011 Results published in the Stroke.
    • 18 Aug 2011 Status changed from active, no longer recruiting to completed.
    • 06 Apr 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top